Full-Time

Senior Quantitative Analytics and Forecasting Manager

Posted on 6/22/2025

Exelixis

Exelixis

1,001-5,000 employees

Develops and commercializes cancer therapies

Compensation Overview

$173k - $246k/yr

+ Bonus + Sales-based Incentive Plan

Senior

Alameda, CA, USA

In Person

Category
Management Consulting
Consulting
Required Skills
SQL
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Bachelor’s degree in related discipline and a minimum of 5 years of related experience; or, Master’s degree in related discipline and a minimum of 3 years of related experience; or, Equivalent combination of education and experience.
  • Strong understanding of pharmaceutical data sources (specialty pharmacy, specialty distributor, claims, Xponent) is required
  • Hands-on experience analyzing large pharmaceutical data sets using advanced statistical techniques is required
  • Proficiency with Office products (Excel, PPT) and SQL is required
Responsibilities
  • Support projects involving secondary data analytics and reporting including business performance tracking, competitive analysis, digital and other promotion effectiveness, resource allocation, segmentation, and targeting.
  • Support the evolution of omnichannel reporting and analytics.
  • Apply and guide usage of analytical techniques to diverse pharmaceutical data sources to address business needs and questions.
  • Translate data and complex analytics into easily consumable and actionable business insights and recommendations, and effectively communicate findings to stakeholders.
  • Support the quarterly demand forecast process including forecast assumption updates, reporting, forecast variance analyses, continued development of the forecast tool and provide forecast-related analytics including assumption impact analyses, patient flow analyses, and persistency analyses.
  • Partner with internal groups (Market Planning, Finance, Supply Chain, Market Access, etc) to understand and integrate key business dynamics into forecast, partner with sales ops to develop and implement IC goals.
  • Support the weekly business performance tracking and reporting process including weekly deep dives into performance metrics to uncover business insights, trends, and drivers.
  • Weekly analysis of trade data to inform on performance and variance from forecast assumptions.
  • Maintenance and continued development of the performance reporting tool and metrics.
  • Partner with internal groups (Data Ops, Market Access, IT) to resolve and understand drivers behind trends and data anomalies.
  • Build peer support and strong internal relationships with colleagues.
Desired Qualifications
  • Experience with oncology and product launches is preferred
  • Prior consulting experience is preferred
  • Vendor management experience is a plus
  • Experience creating dashboards is preferred

Exelixis develops and commercializes medicines specifically for cancer treatment. The company creates therapies that target various biological pathways and are designed to be used in combination with other treatments, which helps to enhance their effectiveness and tolerability. Exelixis primarily focuses on patients with advanced cancers, such as renal cell carcinoma, and engages in extensive research, clinical trials, and obtaining regulatory approvals to introduce new drugs to the market. Unlike many competitors, Exelixis emphasizes a combination approach in its therapies, which can lead to better patient outcomes. The goal of Exelixis is to improve the quality of life for cancer patients and provide them with hope for remission through its drug development efforts.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

San Francisco, California

Founded

1994

Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic partnerships can expand Exelixis' pipeline and market reach.
  • AI-driven drug discovery accelerates identification of novel cancer targets for Exelixis.
  • Telemedicine improves patient monitoring, enhancing outcomes of Exelixis' therapies.

What critics are saying

  • Generic competition may reduce market share for CABOMETYX®.
  • Reliance on future drug approvals may not meet expectations.
  • Need for additional funding may indicate financial pressures.

What makes Exelixis unique

  • Exelixis focuses on combination regimens for advanced cancer treatment.
  • The company targets multiple pathways to create effective and durable cancer therapies.
  • Exelixis has a strong pipeline with four molecules in preclinical stages.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Flexible Work Hours

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Performance Bonus

Employee Stock Purchase Plan

Company News

Medical Update Online
Mar 28th, 2025
Exelixis to present preclinical data for four pipeline molecules at AACR 2025

Exelixis to present preclinical data for four pipeline molecules at AACR 2025.

Defense World
Mar 9th, 2025
Proficio Capital Partners LLC Makes New Investment in Exelixis, Inc. (NASDAQ:EXEL)

Proficio Capital Partners LLC makes new investment in Exelixis, Inc. (NASDAQ:EXEL).

Stock Titan
Feb 13th, 2025
Exelixis to Participate in the Citi 2025 Virtual Oncology Leadership Summit

Exelixis to participate in the Citi 2025 Virtual Oncology Leadership Summit.

MarketBeat
Jan 7th, 2025
Range Financial Group LLC Invests $994,000 in Exelixis, Inc. (NASDAQ:EXEL)

Range Financial Group LLC invests $994,000 in Exelixis, Inc. (NASDAQ:EXEL).

Stock Titan
Jan 6th, 2025
Exelixis to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025

Exelixis to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025.

INACTIVE